How much does Wellcome Genome Campus Development Limited make?

Wellcome Genome Campus Development Limited reported revenue of £3.5m and £584k profit in the year to 30 Sep 2024, according to its accounts filed at Companies House.

How many employees does Wellcome Genome Campus Development Limited have?

Wellcome Genome Campus Development Limited reported an average of 0 employees in the year to 30 Sep 2024.

Is Wellcome Genome Campus Development Limited profitable?

Yes — Wellcome Genome Campus Development Limited reported a profit of £584k in the year to 30 Sep 2024.

Company No. 14378001 · Incorporated 27 Sep 2022

Wellcome Genome Campus Development Limited

Registered name: WELLCOME GENOME CAMPUS DEVELOPMENT LIMITED

Part of Mills & Reeve LLP group

Wellcome Genome Campus Development Limited made £3.5m revenue and £584k profit in the year to 30 Sep 2024.

Wellcome Genome Campus Development Limited’s revenue fell 11% to £3.5m in the year to 30 Sep 2024, with £584k profit and 0 employees. The company is classified under “management of real estate on a fee or contract basis” and is based in Cambridge; we hold 2 years of its filed accounts.

Full P&L filedSection L · Real estate activitiesSIC 68320Management of real estate on a fee or contract basis

Status: Active
Location: Cambridge, East of England
Age: 4 yrs · since 2022
Type: Private Limited Company

Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company's immediate parent undertaking is Urban&Civic Group Limited, a company incorporated in England and Wales.”

Latest accounts · year to 30 Sep 2024

Key figures

Small teamYoung and profitable

Revenue

£3.5m

Growth ▼10.7%

Profit

£584k

Growth ▼62.5%

Profit margin

16.7%

Gross 100%

Employees

Change —

Profit / employee

—

Profitable streak

2yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

2 filed years

Financial history

Multi-year financials, oldest to newest
Year to	30 Sep 2023	30 Sep 2024
Disclosure	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£3.9m	£3.5m
Gross profit	£3.9m	£3.5m
Operating profit	£1.7m	£431k
Profit before tax	£1.6m	£584k
Profit after tax	£1.6m	£584k
Profit (best available)	£1.6m	£584k
Employees (average)	—	0
Ratios
Profit margin	39.9%	16.7%
Gross margin	100%	100%
Growth (year on year)
Revenue growth	—	▼10.7%
Profit growth	—	▼62.5%
Balance sheet — indirect signals, not revenue
Net assets	£1.6m	£2.1m
Debtors	£4.5m	£4.2m
Deferred income	£422k	£523k
Source	FullAccounts · bulk data Apr 2025	FullAccounts · bulk data Apr 2025

Derived from the latest filing

How the business works

Profit margin: 16.7%; Profit ÷ revenue.
Gross margin: 100%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: —; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: 15%; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 119%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲38%; Now £2.1m
Cash at bank: —; Now —
Headcount: —; Now 0
Deferred income: ▲24%; Now £523k
Fixed assets: —; Now —

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

Mills & Reeve LLPultimate parent75–100%
Mills & Reeve Trust Corporation Limited75–100%
Gower Place Investments Limited75–100%
Wellcome Genome Campus Holdings Limited75–100%
Wellcome Genome Campus Development Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (4)

Wellcome Genome Campus LimitedRev. £6.6m · Profit −£2.6m
Wellcome Genome Campus Property LimitedRev. £6.3m · Profit −£4.6m
Hinxton Hall Estate LimitedFigures not disclosed
Hinxton Hall Hotel and Conference Centre LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 30 Sep 2024 (profit £584k), from the Companies House accounts bulk data published Apr 2025. Spotted an error? Request a correction.

Updated from Companies House on 13 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.